Objective: To characterize comorbid chronic conditions, describe health services use, and estimate health care costs among community-dwelling older adults with prior stroke.
Stroke is a leading cause of death and disability among older adults. 1 Due to population aging and greater poststroke survival, 2 an increasing number of older people are living with the effects of stroke.
The frequency of most chronic conditions (CCs), including the co-occurrence of multiple CCs, also increases with age. 3 A recent study found that older adults with prior stroke were more likely to have other CCs than those without prior stroke. 4 Comorbid CCs are associated with greater short-and long-term stroke mortality, 5, 6 worse rehabilitation outcomes, 7, 8 and reduced use of secondary prevention. 9 Most research has focused on concordant comorbid conditions (those related to stroke) and outcomes such as stroke mortality, recurrence, rehabilitation, or stroke-specific health care costs. [10] [11] [12] [13] Little research has fully characterized the frequency of common comorbid CCs or the effects on overall health services use or costs. A more complete understanding of comorbidity among older adults with stroke is necessary for the implementation of interventions that meet the full range of needs in older adults with stroke, including the accommodation of discordant CCs. The overall objective of this study is to examine the relationship between the number of comorbid conditions and health services use among a cohort of community-dwelling older adults living with stroke. The specific objectives are to (1) characterize comorbid CCs, (2) describe their health services use for stroke-related and non-stroke-related reasons over a 5-year period, and (3) estimate the associated health care costs over this period.
METHODS Study design and setting. This is a retrospective cohort study using linked health administrative databases from Ontario, Canada. The vast majority of provincial residents are covered under the public health insurance plan (Ontario Health Insurance Plan [OHIP]), which includes physician visits, acute care hospital use, and home care.
This study was conducted with support from the Aging, Community, and Health Research Unit (ACHRU) at McMaster University. ACHRU was established to design, evaluate, and translate interprofessional community-based programs to improve health care access, health-related quality of life, and health outcomes while reducing costs for older adults with multiple CCs. This study was developed to address ACHRU's information needs for an intervention for older stroke survivors with comorbid CCs.
Data. The databases included the Registered Persons Database
(RPDB) for demographic data, OHIP claims for physician visits, the Discharge Abstract Database (DAD) for inpatient hospitalization records, the National Ambulatory Care Reporting System (NACRS) for emergency department and ambulatory care records, and the Home Care Database for home care service records. Additional databases were accessed for specific diagnostic information, including the Ontario Mental Health Reporting System, the Ontario Cancer Registry, and the Ontario Drug Benefit claims database. All databases, except RPDB, are collected for administrative purposes and submission is mandatory for the relevant health service contact. They have been well-studied for accuracy. Chart re-abstraction studies of NACRS have found 84% interrater reliability on diagnostic elements 14 while those of DAD have found over 80% completeness of diagnostic reporting and 88% positive predictive value of the reported diagnosis. 15 Nonclinical elements, such as service dates, have near perfect agreement with medical charts. 15 A stroke-focused DAD evaluation found 97% complete diagnostic reporting with 90% positive predictive value for diagnosis. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] The data were linked using unique, encoded identifiers and analyzed at the Institute for Clinical Evaluative Sciences (ICES) in Toronto, Canada.
Standard protocol approvals, registrations, and patient consents. This study was approved by the Research Ethics Board at each Sunnybrook Health Sciences Centre and McMaster University (certificate 13-394-C).
Study cohort. The cohort included all individuals 66 years and over who resided in the community and had a diagnosis of stroke as of April 1, 2008 (baseline). We set our lower age limit at 66 years since prescription drug coverage starts at age 65 and a 1-year look-back for relevant prescriptions was required for certain diagnostic definitions. We excluded individuals residing in nursing homes.
We looked for evidence of ischemic or hemorrhagic stroke within the 5 years prior to baseline by searching all DAD diagnostic fields for relevant ICD-10-CA codes, derived from a recent stroke care evaluation in Ontario 27 (appendix e-1 at Neurology. org). We excluded individuals with a new stroke within the 6 months prior to baseline to avoid capturing the postacute period. We further excluded individuals who were 105 years or older, who were receiving palliative care, or who had no health system contact in the 5 years prior to baseline.
From baseline, each individual was followed until the first of nursing home admission, a move out of province, death, or the end of the 5-year follow-up (March 31, 2012) . At the start of each follow-up year, we adjusted the cohort denominator to remove those no longer eligible for inclusion (due to death, nursing home admission, or an out-of-province move).
We described the cohort at baseline by age, sex, neighborhood income, and the presence of comorbid CCs. The comorbid CCs identified were anxiety or depression, arthritis, cancer, cerebral vascular disease (excluding stroke), chronic obstructive pulmonary disease (COPD), dementia, diabetes, upper gastrointestinal bleed, hypertension, ischemic heart disease (IHD), liver disease, osteoporosis/osteopenia, inflammatory bowel disease (IBD), and renal disease (with and without chronic dialysis). These conditions were selected because of their prevalence and relevance to the ACHRU intervention studies. Each condition, except cancer, was defined using either of the following methods: (1) a search for diagnostic codes in the OHIP, DAD, or NACRS databases within the 5 years prior to baseline or specific prescription drug claims within the 1 year prior to baseline; or (2) entry into a diagnosis-specific database created at ICES. Cancer diagnoses were identified using the provincial registry. Details for each diagnosis are listed in appendix e-1; several have been previously validated or use a similar standard approach. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] The extent of comorbidity was estimated by summing across the total number of comorbid conditions at baseline. We grouped the cohort by number of comorbid conditions (0, 1, 2, 3, 4, 5, 6, 7, 8 or more).
Health services utilization variables. We identified all health services utilization from baseline to the end of the 5-year follow-up, including physician visits (to primary and specialist care providers), unplanned emergency department visits, hospitalizations, and home care contacts. We created hospitalization episodes to avoid double-counting interhospital transfers. For each hospitalization episode, we estimated the total length of stay (admission to final discharge) and time in either the intensive care unit (ICU) or as alternate level of care (ALC). ALC refers to when a patient no longer requires hospital care but cannot be discharged due to a lack of alternative services elsewhere. For physician visits, emergency department visits, and hospitalizations, we distinguished between those related to stroke and those for all other reasons (appendix e-2). For home care services, we counted the total number of nursing visits, but the reason for the visit could not be determined.
Statistical analyses and costing. We used descriptive statistics to characterize the cohort including the prevalence of each condition at baseline. For each year of follow-up, we estimated the total amount of each type of health service used by number of comorbid conditions; corresponding estimates of per year and average annual usage were adjusted to the year-specific denominator. Costs, in Canadian dollars, for each type of health service were calculated by multiplying the service volume (either total number of visits or hours of service, depending on type) by the published unit cost (cost per visit or hour, depending on type). Of note, we used all home care visit types (not just nursing visits) to estimate total home care costs. Details on the source of published costs can be found in appendix e-3. Total service costs for each year of follow-up were calculated by adding the total costs per type. Average annual per-patient costs were estimated by dividing total service costs by the number of individuals in the cohort per year. We further estimated the proportion of total health services costs attributed to each of physician visits, emergency department visits, hospitalizations, and home care. Where applicable, costs were standardized to 2012 dollars to facilitate comparisons across years (although the inflation rate in the period was close to zero).
RESULTS
We identified 29,673 communitydwelling older adults with a prior stroke. At baseline (April 1, 2008), 31.9% were 66-74 years, 46.0% 75-84 years, and 22.1% 85 years and older; 50.1% were male. The majority (74.9%) had 3 or more comorbid CCs and only 1% had no CCs. The average number of comorbid conditions was 3.5 with little variation by age. The most common comorbid conditions were hypertension (89.8%), arthritis (65.8%), and IHD (38.1%) (table). One-fifth (21.2%) of the cohort had dementia and 5.9% experienced a mood or anxiety disorder. A total of 60.7% (n 5 18,012) of the cohort was followed for 5 years (until March 31, 2012); 78.5% of censoring was due to death and the remainder due to nursing home admission. Figure 1 displays the average annual number of primary care visits, specialist visits, emergency department visits, acute care hospitalizations, and home care nursing visits stratified by number of comorbid conditions in 2008 and 2012. In each year, the average annual use of primary care visits, specialist visits, emergency department visits, and acute care hospitalizations increased with the number of comorbid conditions. In all cases, use at least tripled among those with 8 or more comorbid conditions relative to those with no comorbid conditions with the most striking increases observed for emergency department visits and acute care hospitalizations. Overall, use of service was predominantly driven by non-stroke-related reasons, even among those with no or only one comorbid condition. Both stroke and non-stroke-related reasons for use increased with the number of comorbid conditions. Average hospital length of stay, ICU stays, and ALC days showed similar increases with greater comorbid conditions (data not shown). The average annual number of home care nursing visits increased from 1.3 visits among those with 0 conditions to 11.8 visits among those with 3 or more conditions ( figure 1E) . Between 2008 and 2012, the average annual number of primary care and specialist visits, regardless of comorbidity, declined from 13.2 to 11.0 and 15.6 to 14.3, respectively. This appeared to be driven by changes in those with the highest level of comorbidity since those with no or one comorbidity showed either consistent or greater average use over time. There was little change in average annual number of hospitalizations or home care nursing visits over time for the full cohort or by comorbidity; while the average annual number of emergency department visits overall was unchanged, there were slight differences by comorbidity with decreased use among those with the highest number of comorbid conditions. Figure 2 displays total health services utilization costs by number of comorbid conditions for 2008. The proportion attributed to each type of health services utilization is shown within the overall cost bars. Total cohort cost was $213.5 million. Total cost increased from $615,000 among those with no comorbid conditions to $42 million among those with 5 comorbid conditions and then declined to $17.6 million among those with 8 or more comorbid conditions. These cost differences reflect both the group size based on number of comorbid conditions and differences in health services utilization. Most notably, the share of costs attributed to acute care (emergency department visits and hospitalizations) increased with comorbidity while the share of costs attributed to physician visits and home care use declined. Data from 2012 showed a similar pattern but lower overall costs, likely due to the smaller cohort size at 5 years (data not shown). Figure 3 displays average annual per-patient costs, adjusted to 2012 dollars, for each study year by number of comorbid CCs. Average annual per-patient costs increased with the number of comorbid conditions but differences widened with increasing comorbidity. For example, in 2008, average per-patient costs were $2,775 for those without comorbid conditions, $3,090 for those with 1, $5,623 for those with 3, $10,671 for those with 5, and $27,898 for those 8 or more comorbid conditions. Overall average per-patient costs in 2008 were $8,223, which is skewed by the greater number of individuals with multiple comorbid conditions. Over the 5 years, the overall average per-patient cost showed a slight decline but this was inconsistent across levels of comorbidity with the greatest change observed among those with the highest level of comorbidity. DISCUSSION We found that in a cohort of older adults with prior stroke, the vast majority were living with multiple comorbid CCs. While concordant conditions, such as hypertension and diabetes, were common, so were discordant conditions, such as arthritis and IBD. We also found that greater comorbidity was associated with higher stroke-and non-stroke-related health services utilization. Not surprisingly, health care costs increased with the number of comorbid CCs, but the main cost drivers shifted from community-based to acute care services.
A striking finding is the sheer volume of health services utilization. For example, in 2008, the average older adult with prior stroke visited a primary care physician over 13 times-more than 1 visit per month-not including specialist visits. It is also striking that the majority of health services use captured here was not directly attributed to stroke, even among those individuals who did not have 1 of the 14 other CCs. While many of these conditions share risk factors or treatment plans with stroke, others do not and may require special consideration in the design or implementation of stroke recovery and secondary prevention programs. For example, arthritis, identified in two-thirds of our cohort, has been associated with poorer functional recovery following stroke. 28 This appears to be attributed to stroke rehabilitation activities that do not accommodate for common arthritis-related limitations and changes to arthritis medications due to cardiovascular risks. 7 Other common conditions, such as COPD and dementia, likely also have implications for rehabilitation and secondary prevention activities.
As with other services, the average annual number of home care nursing visits increased with comorbidity; however, even among the group with Total annual health services utilization costs for community-dwelling older adults who experienced a stroke in 2008 by type of health service and number of chronic conditions ED 5 emergency department; FP 5 family practitioner; GP 5 general practitioner.
Figure 3
Average annual per-patient health services costs for communitydwelling older adults who experienced a stroke between 2008 and 2012, adjusted to 2012 dollars the greatest number of comorbid conditions, the average annual number of visits was low, with an average of only 5 visits per year. Of note, this estimate includes individuals who did not receive home care and may be skewed. At the same, though, it has been well-reported that older adults who experience a stroke often live with long-term functional impairments. 29, 30 Although we cannot speculate based on our data, others have demonstrated ongoing unmet needs for supportive home care services for stroke survivors. 31 We found that the drivers of health care costs varied by the number of comorbid conditions. Physicians, in particular specialists, and home care were the biggest cost contributors in those with few comorbid conditions but acute care was the largest single contributor in those with multiple comorbid conditions. This likely reflects the general increase of acute care use reported elsewhere. 32, 33 Overall costs declined over the 5-year follow-up, likely reflecting the diminishing cohort, but there was little change in the relative contribution of each health service type to costs. Average per-patient costs declined slightly for the group with the greatest number of comorbidities but increased for those with no or few comorbidities. This reflects underlying changes in service utilization and not changing costs since these were standardized to 2012 dollars. Increased costs among those with no or few comorbid conditions may in part be explained by the addition of new diagnoses over the 5 years that we were unable to capture. Regardless, there is a clear increase in average per-patient costs with increasing comorbidity. Future research should also consider the relative effect of specific comorbid conditions on costs, in particular those conditions or groups of conditions associated with highest costs. This work would also benefit from the inclusion of prescription medication costs, given their role in CC management.
This study has several strengths, including our population-based cohort of older adults with prior stroke and the use of administrative data to track health service utilization. We did not restrict the study to stroke-concordant conditions, allowing for a more thorough description of multimorbidity than in many prior studies. This study also has limitations. First, we could only include health services that were covered by the public health insurance system, which means that privately covered home care services were excluded. Second, we were unable to add new diagnoses over follow-up, since it is difficult to capture specific onset dates for most CCs using administrative data. Third, we used a simple count of CCs to estimate the burden of comorbidity since there is little guidance on conceptualizing comorbidity in people with stroke. Future research is needed to better understand the effect of other definitions of comorbidity including concordant/discordant dichotomies, symptom burden, and high counts. Further, we considered only 14 comorbid CCs, so likely underestimate comorbidity in this population; however, our list does include the most prevalent conditions as reported elsewhere. 3 Finally, we used a simple strategy to distinguish stroke-and non-stroke-related health service use, which may underestimate use that could be indirectly attributed to stroke (for example, a fall-related injury that resulted from an impairment due to stroke). Regardless, our findings on the predominance of non-stroke-related use raise an important note of consideration for future evaluations of stroke care programs since it is possible that they would have an effect on overall service use, and not just stroke-specific outcomes.
This study highlights a number of implications for future research, practice, and policy. We found a very high burden of multiple CCs, notably the frequent cooccurrence of discordant CCs. Research is needed to better characterize the interplay between stroke and common discordant conditions, such as arthritis, and the implications for stroke rehabilitation, secondary prevention, and outcomes, as well as non-stroke-related care and outcomes. This is central to the design and implementation of care pathways and programs that accommodate patient preferences and priorities. The increasing use of acute care services with greater comorbidity reinforces the need for investment in community-based care to prevent complications of existing conditions and reduce the need for the most expensive services.
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